Showing 171-180 of 9545 results for "".
Emerging Therapies for AD
https://practicaldermatology.com/topics/atopic-dermatitis/emerging-therapies-for-ad/19639/Increased knowledge of the pathogenesis of AD has led to therapeutic advances for patients, says Emma Guttman, MD.DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/dermwiretv-extra-dr-alexandra-golant-atopic-dermatitis-awareness/26574/DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis AwarenessEmerging Insights into the Immunologic Subtypes of Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37142/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, discusses how new understandings of the immunologic subtypes of atopic dermatitis should influence treatClinical Predictors for Distinguishing Transient Pediatric Atopic Dermatitis from Early-onset Atopic March Cases
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37159/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, talks about clinical predictors for atopic dermatitis vs early-onset atopic march.FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Pico Pick-up: Expanding Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pico-pick-up-expanding-applications/18555/What started as a revolutionary approach to removing tattoos, is finding new applications for facial rejuvenation. The expanding use of picosecond technology is making the investment more attractive for aesthetically-focused practices, notes Dr. Gold.Acquiring An Education In Cosmetic Dermatology
https://practicaldermatology.com/topics/practice-management/acquiring-an-education-in-cosmetic-dermatology/19024/With many residency programs not emphasizing cosmetic dermatology, Kristina Goldenberg, MD gives advice on how to be proactive in achieving an education in aesthetics.Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Aesthetics: A European Perspective
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetics-a-european-perspective/18581/When it comes to cosmetic interventions, philosophies of beauty are similar are both sides of the Atlantic. But the tools to achieve aesthetic improvement are different. Dr. Sabine Zenker discusses what's different in Europe, including the availability of injection systems.Cosmeceuticals: It's All About End Results
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceuticals-it-s-all-about-end-results/18582/End results separate the science from the marketing of topical cosmetic products, says Annie Chiu, MD. She talks about the challenges of formulating and preserving delicate ingredients and explains why packaging is so important. Patients need education about ingredients and packaging, she says, to o